N. Kamaly

Biomaterials · 2012–2016

A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom N. Kamaly trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. O. Farokhzad
  2. Robert Langer
  3. H. Maeda
  4. Mark E. Davis
  5. Jean‐François Lutz
  6. Rakesh K. Jain
  7. J. Siepmann
  8. Allan S. Hoffman
  9. Andrew deMello
  10. Ralph Weissleder

Who trusts N. Kamaly overall

  1. Shreelaxmi Gavas
  2. Sameer Quazi
  3. Xiaoyang Xu
  4. A. Anselmo

Papers from N. Kamaly's perspective

Ordered by how strongly the researchers N. Kamaly trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
  2. Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
  3. Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
  4. Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
  5. Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
  6. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
  7. Pathology: Cancer cells compress intratumour vessels (Nature)
  8. Mediating tumor targeting efficiency of nanoparticles through design. (Nano letters (Print))
  9. Strategies in the design of nanoparticles for therapeutic applications (Nature reviews. Drug discovery)
  10. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. (Journal of the National Cancer Institute)

Their papers